Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Travere Therapeutics, Inc. (NASDAQ: TVTX)
TVTX Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
30.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-4.30%
TVTX Stock Analysis
TVTX
PE Ratio:
TVTX
PEG Ratio:
TVTX
Forward EPS Growth (12 month):
400.00%
TVTX
PS Ratio:
7.8
TVTX
PSG Ratio:
0.2
TVTX
Forward Revenue Growth (12 month):
38.70%
TVTX Articles
No data was found